178 related articles for article (PubMed ID: 34445757)
1. Nitro-Oleic Acid (NO
Braumann S; Schumacher W; Im NG; Nettersheim FS; Mehrkens D; Bokredenghel S; Hof A; Nies RJ; Adler C; Winkels H; Knöll R; Freeman BA; Rudolph V; Klinke A; Adam M; Baldus S; Mollenhauer M; Geißen S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445757
[TBL] [Abstract][Full Text] [Related]
2. Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses.
Ambrozova G; Martiskova H; Koudelka A; Ravekes T; Rudolph TK; Klinke A; Rudolph V; Freeman BA; Woodcock SR; Kubala L; Pekarova M
Free Radic Biol Med; 2016 Jan; 90():252-260. PubMed ID: 26620549
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension.
Klinke A; Möller A; Pekarova M; Ravekes T; Friedrichs K; Berlin M; Scheu KM; Kubala L; Kolarova H; Ambrozova G; Schermuly RT; Woodcock SR; Freeman BA; Rosenkranz S; Baldus S; Rudolph V; Rudolph TK
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):155-62. PubMed ID: 24521348
[TBL] [Abstract][Full Text] [Related]
4. Nitrated fatty acids suppress angiotensin II-mediated fibrotic remodelling and atrial fibrillation.
Rudolph TK; Ravekes T; Klinke A; Friedrichs K; Mollenhauer M; Pekarova M; Ambrozova G; Martiskova H; Kaur JJ; Matthes B; Schwoerer A; Woodcock SR; Kubala L; Freeman BA; Baldus S; Rudolph V
Cardiovasc Res; 2016 Jan; 109(1):174-84. PubMed ID: 26598510
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm Therapy.
Zhao Y; Chang Z; Zhao G; Lu H; Xiong W; Liang W; Wang H; Villacorta L; Garcia-Barrio MT; Zhu T; Guo Y; Fan Y; Chang L; Schopfer FJ; Freeman BA; Zhang J; Chen YE
Cardiovasc Drugs Ther; 2021 Oct; 35(5):939-951. PubMed ID: 32671602
[TBL] [Abstract][Full Text] [Related]
6. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
Su W; Wang H; Feng Z; Sun J
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
[TBL] [Abstract][Full Text] [Related]
7. Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy.
Giam B; Chu PY; Kuruppu S; Smith AI; Horlock D; Murali A; Kiriazis H; Du XJ; Kaye DM; Rajapakse NW
Exp Physiol; 2018 Dec; 103(12):1593-1602. PubMed ID: 30311699
[TBL] [Abstract][Full Text] [Related]
8. Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.
Li J; Gresham KS; Mamidi R; Doh CY; Wan X; Deschenes I; Stelzer JE
Int J Cardiol; 2018 Dec; 273():168-176. PubMed ID: 30279005
[TBL] [Abstract][Full Text] [Related]
9. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
[TBL] [Abstract][Full Text] [Related]
10. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy.
Hongo M; Ryoke T; Schoenfeld J; Hunter J; Dalton N; Clark R; Lowe D; Chien K; Ross J
Basic Res Cardiol; 2000 Dec; 95(6):431-41. PubMed ID: 11192363
[TBL] [Abstract][Full Text] [Related]
11. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.
Rom O; Xu G; Guo Y; Zhu Y; Wang H; Zhang J; Fan Y; Liang W; Lu H; Liu Y; Aviram M; Liu Z; Kim S; Liu W; Wang X; Chen YE; Villacorta L
EBioMedicine; 2019 Mar; 41():62-72. PubMed ID: 30772307
[TBL] [Abstract][Full Text] [Related]
12. Nitro-oleic acid-mediated blood-brain barrier protection reduces ischemic brain injury.
Zhou C; Su M; Sun P; Tang X; Yin KJ
Exp Neurol; 2021 Dec; 346():113861. PubMed ID: 34499902
[TBL] [Abstract][Full Text] [Related]
13. Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome.
Nettersheim FS; Lemties J; Braumann S; Geißen S; Bokredenghel S; Nies R; Hof A; Winkels H; Freeman BA; Klinke A; Rudolph V; Baldus S; Mehrkens D; Mollenhauer M; Adam M
Cardiovasc Res; 2022 Jul; 118(9):2211-2225. PubMed ID: 34324651
[TBL] [Abstract][Full Text] [Related]
14. Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice.
Wang H; Liu H; Jia Z; Olsen C; Litwin S; Guan G; Yang T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F754-62. PubMed ID: 20032118
[TBL] [Abstract][Full Text] [Related]
15. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.
Arber S; Hunter JJ; Ross J; Hongo M; Sansig G; Borg J; Perriard JC; Chien KR; Caroni P
Cell; 1997 Feb; 88(3):393-403. PubMed ID: 9039266
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.
Mohapatra B; Jimenez S; Lin JH; Bowles KR; Coveler KJ; Marx JG; Chrisco MA; Murphy RT; Lurie PR; Schwartz RJ; Elliott PM; Vatta M; McKenna W; Towbin JA; Bowles NE
Mol Genet Metab; 2003; 80(1-2):207-15. PubMed ID: 14567970
[TBL] [Abstract][Full Text] [Related]
17. Nitro-Oleic Acid Inhibits Stemness Maintenance and Enhances Neural Differentiation of Mouse Embryonic Stem Cells via STAT3 Signaling.
Pereckova J; Pekarova M; Szamecova N; Hoferova Z; Kamarytova K; Falk M; Perecko T
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576143
[TBL] [Abstract][Full Text] [Related]
18. Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.
Cole MP; Rudolph TK; Khoo NK; Motanya UN; Golin-Bisello F; Wertz JW; Schopfer FJ; Rudolph V; Woodcock SR; Bolisetty S; Ali MS; Zhang J; Chen YE; Agarwal A; Freeman BA; Bauer PM
Circ Res; 2009 Nov; 105(10):965-72. PubMed ID: 19797175
[TBL] [Abstract][Full Text] [Related]
19. Nitro-fatty acids suppress ischemic ventricular arrhythmias by preserving calcium homeostasis.
Mollenhauer M; Mehrkens D; Klinke A; Lange M; Remane L; Friedrichs K; Braumann S; Geißen S; Simsekyilmaz S; Nettersheim FS; Lee S; Peinkofer G; Geisler AC; Geis B; Schwoerer AP; Carrier L; Freeman BA; Dewenter M; Luo X; El-Armouche A; Wagner M; Adam M; Baldus S; Rudolph V
Sci Rep; 2020 Sep; 10(1):15319. PubMed ID: 32948795
[TBL] [Abstract][Full Text] [Related]
20. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
Huby AC; Turdi S; James J; Towbin JA; Purevjav E
Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
